<DOC>
	<DOCNO>NCT01465282</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness 3 dose strength CT327 ointment ( 0.05 % , 0.1 % 0.05 % w/w ) compare placebo , apply twice daily 8 week , psoriatic plaque patient psoriasis vulgaris .</brief_summary>
	<brief_title>Evaluation Efficacy , Safety Toleration CT327 Ointment Patients With Psoriasis Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Male female subject age least 18 year . Stable psoriasis vulgaris Subjects guttate , erythrodermic , exfoliative pustular psoriasis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>psoriasis vulgaris</keyword>
	<keyword>topical ointment</keyword>
</DOC>